Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;35(9):2703-2705.
doi: 10.1038/s41375-021-01270-w. Epub 2021 May 13.

COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia

Lindsey E Roeker  1 , David A Knorr  2 , Meghan C Thompson  2 , Mariely Nivar  2 , Sonia Lebowitz  2 , Nicole Peters  3 , Isaac Deonarine Jr  2 , Saddia Momotaj  2 , Saumya Sharan  4 , Vanessa Chanlatte  2 , Bianca Hampton  2 , Liana Butala  3 , Lindsay Amato  2 , Angela Richford  4 , Jessica Lunkenheimer  2 , Kristen Battiato  2 , Carissa Laudati  3 , Anthony R Mato  2
Affiliations

COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia

Lindsey E Roeker et al. Leukemia. 2021 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

LER has served as a consultant for AbbVie, AstraZeneca, Pharmacyclics, Vaniam group, and Verastem, holds minority ownership interest in Abbott Laboratories, and has received research funding (paid to the institution) from Pfizer and Aptose Biosciences outside of the submitted work. DAK receives research support on COVID-19 from Pfizer. MCT has received honoraria from MJH Life Sciences, VJ Heme Onc, Curio Science. KB has consulted for AbbVie and Janssen. ARM has served as a consultant and received research funding from Curio Science, TG Therapeutics, Celgene, Janssen; AbbVie, Adaptive, Loxo, Nurix, Genmab, Genentech, Pfizer, Octopharma, Pharmacyclics, AstraZeneca, Sunesis, DTRM, Gilead, and Johnson & Johnson. He served as DSMB member at TG Therapeutics. All other authors declare no competing interest.

References

    1. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15.. doi: 10.1056/NEJMoa2034577. - DOI - PMC - PubMed
    1. Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N Engl J Med. 2021;384:403–16.. doi: 10.1056/NEJMoa2035389. - DOI - PMC - PubMed
    1. Pleyer C, Ali MA, Cohen JI, Tian X, Soto S, Ahn IE, et al. Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines. Blood. 2021;137:185–9. doi: 10.1182/blood.2020008758. - DOI - PMC - PubMed
    1. Mauro FR, Giannarelli D, Galluzzo CM, Vitale C, Visentin A, Riemma C, et al. Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL) Leukemia. 2021;35:737–46.. doi: 10.1038/s41375-020-0884-z. - DOI - PubMed
    1. Sun C, Gao J, Couzens L, Tian X, Farooqui MZ, Eichelberger MC, et al. Seasonal influenza vaccination in patients with chronic lymphocytic leukemia treated with Ibrutinib. JAMA Oncol. 2016;2:1656–7. doi: 10.1001/jamaoncol.2016.2437. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources